Interview: Ko-Chung Lin PhD – Founder & CEO, PharmaEssentia, Taiwan
Ko-Chung Lin, founder and CEO of PharmaEssentia, documents the main specificities of the company’s groundbreaking…
Address: 13F, No.3 Park St NanKang Dist. Taipei, Taiwan 115 ,Taiwan
Tel: +886-2-2655-7688
Web: http://www.pharmaessentia.com/
PharmaEssentia Corporation is a global pharmaceutical company founded by a group of eminent Taiwanese-American scientists in August 2003. Its mission is to discover, develop, and deliver to the market a range of efficacious, safe and cost-effective therapeutic products for human disease through new drug research and development. Its mission is a never-ceasing quest for the improvement of the health and quality of human life.
PharmaEssentia strives to utilize the most modern biotechnology science to fulfill its mission, under the following strategy:
1. Build and position intellectual property for all desired target areas, and to generate short term revenue to boost the
company’s market value.
2. Leverage strategic collaborations to minimize capital investment and to facilitate the delivery of product to the market. 3. Strengthen platform technology to become a worldleading biotechnology company.
Ko-Chung Lin, founder and CEO of PharmaEssentia, documents the main specificities of the company’s groundbreaking…
When you created PharmaEssentia, what was the rationale behind coming back to Taiwan? The foundation for the…
Charles Chen of Taiwanese firm Medigen Vaccines Biologics Corp (MVC) shares his career journey, the company’s…
Johnsee Lee and Eric Yang of Taiwanese precision medicine diagnostics firm Quark Biosciences outline their…
Louis Cheng, CEO of Taiwanese firm Leadgene Biomedical, introduces the company’s expertise in antibody…
Taiwan Bio Industry Organization Chairman Dr Johnsee Lee outlines the Taiwanese biopharmaceutical industry’s…
Taiwan, although small in size, boasts a strong culture of innovation as well as a universal healthcare system that…
Long overshadowed by larger and more well-known neighbours, the island of Taiwan is nonetheless cultivating an…
While Taiwanese pharmaceutical and biotech players have traditionally set their sights on the US as a key market,…
All country managers of multinational pharma companies need to strike the balance between having a global outlook…
Nutrarex Biotech is a Taiwanese private label contract manufacturer of functional supplements, exclusively…
In an effort to enhance trade and cooperation with other countries in the region and reduce dependency on mainland…
Within Taiwan’s evolving medical device sector, many innovative startups are exploring breakthrough ideas which…
Mark Yang, CEO of GaleMed, elaborates on the medical device manufacturer’s transition from a privately-owned…